$TDOC
Teladoc Health, Inc.

2019 Q4 Form 10-Q Financial Statement

#000155837019009443 Filed on October 30, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $156.5M $138.0M $111.0M
YoY Change 27.5% 24.34% 61.52%
Cost Of Revenue $55.36M $42.80M $34.17M
YoY Change 38.29% 25.26% 104.59%
Gross Profit $101.1M $95.17M $76.80M
YoY Change 22.27% 23.93% 47.97%
Gross Profit Margin 64.63% 68.98% 69.21%
Selling, General & Admin $61.23M $54.80M $46.62M
YoY Change 20.14% 17.56% -3.88%
% of Gross Profit 60.55% 57.58% 60.7%
Research & Development $16.25M $15.75M $13.58M
YoY Change 19.95% 15.98% 35.77%
% of Gross Profit 16.06% 16.55% 17.68%
Depreciation & Amortization $11.09M $11.42M $9.750M
YoY Change 16.13% 17.13% 52.11%
% of Gross Profit 10.97% 12.0% 12.7%
Operating Expenses $77.48M $70.55M $60.19M
YoY Change 20.1% 17.2% -7.25%
Operating Profit -$15.59M -$19.94M -$15.78M
YoY Change -12.61% 26.4% 21.37%
Interest Expense -$7.600M -$7.700M -$7.700M
YoY Change 13.43% 0.0% -6.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$23.17M -$27.64M -$23.44M
YoY Change -5.43% 17.92% -24.86%
Income Tax -$4.125M -$7.300M -$180.0K
% Of Pretax Income
Net Earnings -$19.04M -$20.35M -$23.26M
YoY Change -23.45% -12.54% -25.67%
Net Earnings / Revenue -12.17% -14.75% -20.97%
Basic Earnings Per Share
Diluted Earnings Per Share -$261.7K -$281.2K -$341.6K
COMMON SHARES
Basic Shares Outstanding 72.38M 72.04M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $517.1M $490.9M $473.0M
YoY Change 8.05% 3.78% 173.41%
Cash & Equivalents $514.4M $475.2M $457.6M
Short-Term Investments $2.711M $15.63M $15.00M
Other Short-Term Assets $14.00M $13.00M $11.00M
YoY Change 27.27% 18.18% 57.14%
Inventory $0.00
Prepaid Expenses
Receivables $56.95M $53.70M $40.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $588.0M $558.0M $523.0M
YoY Change 10.37% 6.68% 152.66%
LONG-TERM ASSETS
Property, Plant & Equipment $10.30M $10.02M $10.00M
YoY Change 1.46% 0.21% 0.0%
Goodwill $746.1M $737.6M
YoY Change 1.2%
Intangibles $225.5M $228.8M
YoY Change -8.87%
Long-Term Investments
YoY Change
Other Assets $6.545M $6.367M $1.000M
YoY Change 367.17% 536.7% 0.0%
Total Long-Term Assets $1.015B $1.010B $1.012B
YoY Change 1.88% -0.15% 50.15%
TOTAL ASSETS
Total Short-Term Assets $588.0M $558.0M $523.0M
Total Long-Term Assets $1.015B $1.010B $1.012B
Total Assets $1.603B $1.568B $1.535B
YoY Change 4.84% 2.18% 74.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.075M $6.068M $5.000M
YoY Change 16.81% 21.36% 150.0%
Accrued Expenses $58.00M $54.00M $38.00M
YoY Change 41.46% 42.11% 26.67%
Deferred Revenue $12.47M $14.36M
YoY Change 62.95%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $90.18M $85.20M $58.00M
YoY Change 44.43% 46.9% 41.46%
LONG-TERM LIABILITIES
Long-Term Debt $440.0M $434.0M $409.0M
YoY Change 6.02% 6.11% 10.24%
Other Long-Term Liabilities $9.239M $7.156M $6.000M
YoY Change 49.23% 19.27% -25.0%
Total Long-Term Liabilities $9.239M $7.156M $415.0M
YoY Change 49.23% -98.28% 9.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.18M $85.20M $58.00M
Total Long-Term Liabilities $9.239M $7.156M $415.0M
Total Liabilities $99.42M $92.36M $507.0M
YoY Change 44.86% -81.78% 16.82%
SHAREHOLDERS EQUITY
Retained Earnings -$507.5M -$488.5M
YoY Change 24.19%
Common Stock $1.539B $1.510B
YoY Change 7.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.014B $993.7M $1.028B
YoY Change
Total Liabilities & Shareholders Equity $1.603B $1.568B $1.535B
YoY Change 4.84% 2.18% 74.23%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$19.04M -$20.35M -$23.26M
YoY Change -23.45% -12.54% -25.67%
Depreciation, Depletion And Amortization $11.09M $11.42M $9.750M
YoY Change 16.13% 17.13% 52.11%
Cash From Operating Activities $18.12M $13.49M $10.18M
YoY Change 630.65% 32.51% -186.64%
INVESTING ACTIVITIES
Capital Expenditures -$3.390M -$3.290M -$2.090M
YoY Change 16.1% 57.42% 7.73%
Acquisitions
YoY Change
Other Investing Activities $12.94M $16.47M $2.550M
YoY Change -132.82% 545.88% -100.58%
Cash From Investing Activities $9.540M $13.20M $460.0K
YoY Change -122.53% 2769.57% -100.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.04M 9.150M 341.3M
YoY Change 34.77% -97.32% 172.21%
NET CHANGE
Cash From Operating Activities 18.12M 13.49M 10.18M
Cash From Investing Activities 9.540M 13.20M 460.0K
Cash From Financing Activities 10.04M 9.150M 341.3M
Net Change In Cash 37.70M 35.84M 352.0M
YoY Change -216.29% -89.82% -207.9%
FREE CASH FLOW
Cash From Operating Activities $18.12M $13.49M $10.18M
Capital Expenditures -$3.390M -$3.290M -$2.090M
Free Cash Flow $21.51M $16.78M $12.27M
YoY Change 298.33% 36.76% -225.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2018Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2019Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2019Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72356849
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70516249
tdoc Number Of Service Corporations Consolidated As Variable Interest Entities
NumberOfServiceCorporationsConsolidatedAsVariableInterestEntities
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
dei Entity Central Index Key
EntityCentralIndexKey
0001477449
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37477
dei Entity Registrant Name
EntityRegistrantName
TELADOC HEALTH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3705970
dei Entity Address Address Line1
EntityAddressAddressLine1
2 Manhattanville Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 203
dei Entity Address City Or Town
EntityAddressCityOrTown
Purchase
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10577
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
635-2002
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
TDOC
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3382000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
72382343
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475242000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
423989000
CY2019Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
15633000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
54545000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3287000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53669000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43571000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13416000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10631000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
557960000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
532736000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10021000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10148000
CY2019Q3 us-gaap Goodwill
Goodwill
737647000
CY2018Q4 us-gaap Goodwill
Goodwill
737197000
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
228838000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
247394000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27596000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6367000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1401000
CY2019Q3 us-gaap Assets
Assets
1568429000
CY2018Q4 us-gaap Assets
Assets
1528876000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6068000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7769000
CY2019Q3 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
53822000
CY2018Q4 tdoc Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current
AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
26801000
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25312000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27869000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
85202000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
62439000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7156000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6191000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25853000
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
22720000
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32444000
CY2019Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
433760000
CY2018Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
414683000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72356849
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42799000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34167000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
129110000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
88707000
CY2019Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
31321000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
295166000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70516249
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
72000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
70000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1510205000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1434780000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-488481000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-408661000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28058000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13070000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
993738000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1013119000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1568429000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1528876000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
137969000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
110962000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
396818000
CY2018Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
21668000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
84341000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
61554000
CY2019Q3 us-gaap Selling Expense
SellingExpense
16120000
CY2018Q3 us-gaap Selling Expense
SellingExpense
16303000
us-gaap Selling Expense
SellingExpense
48164000
us-gaap Selling Expense
SellingExpense
44645000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15746000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48398000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40829000
CY2019Q3 tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
1634000
CY2018Q3 tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
807000
tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
5239000
tdoc Legal And Regulatory Expense
LegalAndRegulatoryExpense
2491000
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1995000
CY2018Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1588000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4143000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
8957000
CY2018Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1430000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5500000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38681000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30314000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
113212000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80455000
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9617000
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9746000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
29065000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
26045000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
157913000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
126740000
us-gaap Costs And Expenses
CostsAndExpenses
461672000
us-gaap Costs And Expenses
CostsAndExpenses
348183000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19944000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15778000
us-gaap Operating Income Loss
OperatingIncomeLoss
-64854000
us-gaap Operating Income Loss
OperatingIncomeLoss
-53017000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7700000
CY2018Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7666000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21432000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-19449000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27644000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23444000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-86286000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72466000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7298000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-180000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6466000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-261000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20346000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-23264000
us-gaap Net Income Loss
NetIncomeLoss
-79820000
us-gaap Net Income Loss
NetIncomeLoss
-72205000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.11
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72151094
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68247655
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71601790
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64363943
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20346000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-23264000
us-gaap Net Income Loss
NetIncomeLoss
-79820000
us-gaap Net Income Loss
NetIncomeLoss
-72205000
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-23000
CY2018Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
11000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
37000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
52000
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15493000
CY2018Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1840000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15025000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8498000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-15516000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1829000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-30150000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1001558000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14988000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8446000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35862000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25093000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94808000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-80651000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1013119000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8854000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13523000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3788000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6847000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1875000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17368000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4316000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-29324000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1002640000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9119000
CY2019Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
8000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17833000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15516000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20346000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
993738000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
558903000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8643000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7832000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-648000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-23862000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
550868000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7122000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
91392000
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1423000
CY2018Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
68564000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11059000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5969000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-25079000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
699380000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10433000
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
330856000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12195000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1829000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-23264000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
1027771000
us-gaap Net Income Loss
NetIncomeLoss
-79820000
us-gaap Net Income Loss
NetIncomeLoss
-72205000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33860000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26045000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1717000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1535000
us-gaap Share Based Compensation
ShareBasedCompensation
48245000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
327000
us-gaap Share Based Compensation
ShareBasedCompensation
31086000
tdoc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-10288000
tdoc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-1907000
tdoc Accretion Of Interest
AccretionOfInterest
19422000
tdoc Accretion Of Interest
AccretionOfInterest
13593000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5500000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12386000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7535000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2219000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1656000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-73000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1976000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-357000
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
21012000
tdoc Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation
7561000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1813000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1991000
tdoc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1481000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2599000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
340000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11747000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7336000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2847000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2732000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
4658000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2758000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12141000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
39165000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
79470000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
10000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5500000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
5000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
11204000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
282487000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15466000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-215148000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24820000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26198000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
279147000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
330856000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1875000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1423000
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
-1642000
tdoc Cash Related To Tax Withholding For Share Based Compensation Net
CashRelatedToTaxWithholdingForShareBasedCompensationNet
539000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25053000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
638163000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
52266000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
415679000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1013000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-942000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
423989000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42817000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
475242000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
457554000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
846000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
238000
us-gaap Interest Paid
InterestPaid
6112000
us-gaap Interest Paid
InterestPaid
4125000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Note 1. Organization and Description of Business</b></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">Teladoc, Inc. was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. Effective August 10, 2018, Teladoc, Inc. changed its corporate name to Teladoc Health, Inc. Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health” or the “Company”. The Company’s principal executive office is located in Purchase, New York. Teladoc Health is the global leader in providing virtual healthcare services with a focus on high quality, lower costs, and improved outcomes around the world.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">On July 26, 2018, Teladoc Health completed a follow-on public offering (the “July Offering”) in which the Company issued and sold 5,000,000 shares of common stock, at an issuance price of $66.28 per share. The Company received net proceeds of $330.9 million after deducting offering expenses of $0.5 million.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">On May 31, 2018, the Company completed the acquisition of Advance Medical-Health Care Management Services, S.A. (“Advance Medical”), a leading global virtual healthcare provider. See Note 4 “Business Acquisition” for additional information.</p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">On May 8, 2018, the Company issued, at par value, $287.5 million aggregate principal amount of 1.375% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear cash interest at a rate of 1.375% per year, payable semi-annually in arrears on May 15 and November 15 of each year. The 2025 Notes will mature on May 15, 2025. The net proceeds to the Company from the offering were $279.1 million after deducting offering costs of approximately $8.4 million. </p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
tdoc Number Of Professional Associations Consolidated As Variable Interest Entities
NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities
2
tdoc Number Of Professional Corporations Consolidated As Variable Interest Entities
NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities
14
tdoc Contract With Customer Term
ContractWithCustomerTerm
P1Y
tdoc Payment Terms
PaymentTerms
P30D
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
137969000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
110962000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
396818000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
295166000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53700000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6700000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4000000.0
CY2019Q3 tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
900000
CY2018Q3 tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
600000
tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
2100000
tdoc Contract With Customer Refunds Issued
ContractWithCustomerRefundsIssued
2200000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
247394000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8700000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26400000
CY2019Q3 tdoc Other Current Liabilities Clients Guarantees
OtherCurrentLiabilitiesClientsGuarantees
2929000
CY2018Q4 tdoc Other Current Liabilities Clients Guarantees
OtherCurrentLiabilitiesClientsGuarantees
2910000
CY2019Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1250000
CY2018Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1073000
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3889000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
883000
CY2019Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4513000
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2610000
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
313313000
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
84475000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
228838000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
305658000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
58264000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22900000
CY2018Q4 us-gaap Goodwill
Goodwill
737197000
CY2017Q4 us-gaap Goodwill
Goodwill
498520000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
10604000
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
250120000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-10154000
CY2018 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-11443000
CY2019Q3 us-gaap Goodwill
Goodwill
737647000
CY2018Q4 us-gaap Goodwill
Goodwill
737197000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2206000
CY2019Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2583000
CY2018Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
167000
CY2019Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
101000
CY2018Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
53000
CY2019Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3736000
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
644000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5172000
CY2019Q3 tdoc Accrued Earn Out Current
AccruedEarnOutCurrent
663000
us-gaap Operating Lease Cost
OperatingLeaseCost
6073000
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
230000
us-gaap Variable Lease Cost
VariableLeaseCost
698000
CY2019Q3 us-gaap Lease Cost
LeaseCost
2436000
us-gaap Lease Cost
LeaseCost
6771000
CY2019Q3 tdoc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
53822000
CY2018Q4 tdoc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
26801000
us-gaap Operating Lease Payments
OperatingLeasePayments
5981000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4817000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0650
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6943000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5961000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5768000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5685000
CY2019Q3 tdoc Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
13579000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
37936000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6911000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31025000
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1900000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1264000
CY2019Q3 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
6650000
CY2018Q4 tdoc Accrued Consulting And Customer Service Fees Current
AccruedConsultingAndCustomerServiceFeesCurrent
6569000
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14358000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7650000
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6078000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2978000
CY2019Q3 tdoc Line Of Credit Facility Amount Utilized For Facility Security Deposits
LineOfCreditFacilityAmountUtilizedForFacilitySecurityDeposits
1400000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17354000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12195000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
48245000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31086000
CY2019Q3 tdoc Income Tax Benefit Related To Intercompany Transfer
IncomeTaxBenefitRelatedToIntercompanyTransfer
8100000
tdoc Indefinite Lived Net Operating Loss Maximum Percentage Allowed To Be Netted Against Deferred Tax Liability Associated With Goodwill
IndefiniteLivedNetOperatingLossMaximumPercentageAllowedToBeNettedAgainstDeferredTaxLiabilityAssociatedWithGoodwill
0.80
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21

Files In Submission

Name View Source Status
0001558370-19-009443-index-headers.html Edgar Link pending
0001558370-19-009443-index.html Edgar Link pending
0001558370-19-009443.txt Edgar Link pending
0001558370-19-009443-xbrl.zip Edgar Link pending
ex-10d1.htm Edgar Link pending
ex-10d2.htm Edgar Link pending
ex-10d3.htm Edgar Link pending
ex-10d4.htm Edgar Link pending
ex-10d5.htm Edgar Link pending
ex-10d6.htm Edgar Link pending
ex-10d7.htm Edgar Link pending
ex-10d8.htm Edgar Link pending
ex-10d9.htm Edgar Link pending
ex-31d1.htm Edgar Link pending
ex-31d2.htm Edgar Link pending
ex-32d1.htm Edgar Link pending
ex-32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tdoc-20190930.xsd Edgar Link pending
tdoc-20190930x10qcd3842.htm Edgar Link pending
tdoc-20190930x10qcd3842_htm.xml Edgar Link completed
tdoc-20190930_cal.xml Edgar Link unprocessable
tdoc-20190930_def.xml Edgar Link unprocessable
tdoc-20190930_lab.xml Edgar Link unprocessable
tdoc-20190930_pre.xml Edgar Link unprocessable